RELIEF closes CHF 10m private placement: the advisors

RELIEF THERAPEUTICS Holding AG, a biopharmaceutical company with its lead compound RLF-100TM (Aviptadil) in advanced clinical development to treat severe COVID-19 patients, has entered into a binding agreement with a single healthcare-dedicated U.S. institutional investor to purchase in a private placement Relief shares of CHF 10m, to be delivered from Relief’s treasury shares that were issued out of its authorized share capital under exclusion of the existing shareholders’ pre-emptive rights. The transaction closed on 18 March 2021. H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.

The advisors

VISCHER advised Relief regarding the Swiss legal aspects of this transaction with Akerman LLP advising on U.S. laws. The team led by partner Dr. Robert Bernet (Corporate/M&A – pictured right) comprised Dr. Peter Kühn (Counsel, Corporate/M&A) and Christian Schneiter (Associate, Banking & Finance).

Pestalozzi advised H.C. Wainwright. The team included Christian Leuenberger (Lead Partner – Capital Markets, Corporate/M&A – pictured left), Severin Roelli (Partner – Corpoarte/M&A), Manu Ferro (Associate – Banking & Finance).

RELIEF closes CHF 10m private placement: the advisors


Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2023 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram